Zoe M. Weinstein, MD, MS, is a graduate of Boston University’s Addiction Medicine Fellowship and board certified in Internal Medicine and Addiction Medicine. She has been the Director of Boston Medical Center’s interdisciplinary addiction consult service since July 2016. She has been NIDA grant funded as a co-investigator on multiple studies to deliver training and technical assistance to interdisciplinary provider teams (physicians, nurse practitioners, social workers, addiction counselors and recovery coaches) to expand treatment for opioid use disorder among hospitalized patients in New York City public hospitals as well as hospitals in Massachusetts as part of the HEALing Communities Study. She is currently site-PI of two NIDA Clinical Trial Network studies focused on inpatient addiction care. Her clinical and research work are also focused on long-term Office-Based Addiction Treatment (OBAT) with buprenorphine. She currently serves as Associate Director of Boston University’s Addiction Medicine Fellowship Program, a board member of AMERSA and is a site medical director of a local methadone clinic.
Diversity, Equity, Inclusion and Accessibility
As a graduate of BU's Women's Leadership program, I am dedicated to serving as a career mentor and peer mentor to trainees and faculty who identify as women. As the director of the Addiction Consult Service, I am dedicated to equity and diversity in the hiring process as well as retaining and promoting staff from diverse backgrounds, especially staff who identify as BIPOC, LGBTQIA+,and those with lived experience with substance use. As one of the Associate Program Directors for the Addiction Medicine Fellowship, I have collaborated with the rest of the fellowship leadership on completely revising the interview process to a structured interview to increase diversity, equity and accessibility of the fellowship program and increase the diversity of the addiction workforce. This has been done in partnership with the Inclusion Diversity & Equity In Addiction medicine, Addiction health professions, and Addiction research (IDEAAA) Program and the Recognizing and Eliminating Disparities in Addiction through Culturally-informed Healthcare (REACH Program).
I am personally committed to continuing to explore and address my own biases, including participating in Boston University's Bias Reduction in Internal Medicine training, the Conversations on Race/Equity discussion series, and the DOM Reads book club.
Faculty
Boston University Chobanian & Avedisian School of Medicine
Medicine
Clinical Addiction Research and Education Unit
This tab shows grant data from BMC Sponsored Research. It includes:
- Grant title
- Project period and this person’s role on the grant
- PI name, if this person is not the PI (the name will link if PI has a BU Profile)
- Funding source(s). An arrow indicates the flow of funding if multiple sponsors.
- Some grants will show an agency award/project number, and may be a link.
- Data is sorted by project end date, and updated monthly.
This tab shows grant data from BU Sponsored Research. It includes:
- Grant title
- Project period and this person’s role on the grant
- PI name, if this person is not the PI (the name will link if PI has a BU Profile)
- Funding source(s). An arrow indicates the flow of funding if multiple sponsors.
- Some grants will show an agency award/project number, and may be a link.
- Data is sorted by project end date, and updated monthly.
This tab shows grant data that did not automatically get imported into Profiles
from BU or BMC sources.
- Grant title
- Project period and this person’s role on the grant
- PI name, if this person is not the PI (the name will link if PI has a BU Profile)
- Funding source(s). An arrow indicates the flow of funding if multiple sponsors.
- Some grants will show an agency award/project number, and may be a link.
- Data is sorted by project end date, and updated monthly.
This tab shows grant data from the Boston VA. We are only showing grant title, and only for people in the role of PI.
Preventing Bacterial and Viral Infections Among Injection Drug users09/09/2016 - 04/30/2020 (PI)
Trustees of Boston University NIH-NIDA5R01DA034957-06
Next Generation Award for Adolescent Substance Use Prevention-Zoe Weinstein07/01/2014 - 06/30/2015 (PI)
American Board of Addiction Medicine Foundation
|
Yr
|
Title
|
Project-Sub Proj
|
Pubs
|
Publications listed below are automatically derived from MEDLINE/PubMed and other
sources, which might result in incorrect or missing publications. Faculty can
login
to make corrections and additions.
-
Rozansky H, Awtry E, Weinstein ZM, Peterkin AF. Grayken lessons: the role of an interdisciplinary endocarditis working group in evaluating and optimizing care for a woman with opioid use disorder requiring a second tricuspid valve replacement. Addict Sci Clin Pract. 2023 Feb 07; 18(1):9.View Related Profiles. PMID: 36750906; PMCID: PMC9904874; DOI: 10.1186/s13722-023-00360-7;
-
Peterkin AF, Jawa R, Menezes K, You J, Cabral H, Ruiz-Mercado G, Park TW, Kehoe J, Taylor JL, Weinstein ZM. Pre-Paid Phone Distribution: A Tool for Improving Healthcare Engagement for People with Substance Use Disorder. Subst Use Misuse. 2023; 58(4):585-589.View Related Profiles. PMID: 36695079; DOI: 10.1080/10826084.2023.2170184;
-
Laks J, Walley AY, Bagley SM, Barber CM, Gaeta JM, Neville LA, Peterkin AF, Rosenthal E, Saia KA, Weinstein ZM, Harris MTH. Developing a Women's Health track within addiction medicine fellowship: reflections and inspirations. Addict Sci Clin Pract. 2023 Jan 09; 18(1):3.View Related Profiles. PMID: 36617557; PMCID: PMC9827632; DOI: 10.1186/s13722-022-00357-8;
-
-
Calcaterra SL, Martin M, Bottner R, Englander H, Weinstein Z, Weimer MB, Lambert E, Herzig SJ. Management of opioid use disorder and associated conditions among hospitalized adults: A Consensus Statement from the Society of Hospital Medicine. J Hosp Med. 2022 Sep; 17(9):744-756. PMID: 35880813; PMCID: PMC9474708; DOI: 10.1002/jhm.12893;
-
Calcaterra SL, Bottner R, Martin M, Englander H, Weinstein ZM, Weimer MB, Lambert E, Ronan MV, Huerta S, Zaman T, Ullal M, Peterkin AF, Torres-Lockhart K, Buresh M, O'Brien MT, Snyder H, Herzig SJ. Management of opioid use disorder, opioid withdrawal, and opioid overdose prevention in hospitalized adults: A systematic review of existing guidelines. J Hosp Med. 2022 Sep; 17(9):679-692.View Related Profiles. PMID: 35880821; PMCID: PMC9474657; DOI: 10.1002/jhm.12908;
-
Buresh M, Nahvi S, Steiger S, Weinstein ZM. Adapting methadone inductions to the fentanyl era. J Subst Abuse Treat. 2022 Oct; 141:108832. PMID: 35870437
-
Datar Y, Yin K, Wang Y, Lawrence KW, Awtry EH, Cervantes-Arslanian AM, Kimmel SD, Fagan MA, Weinstein ZM, Karlson KJ, McAneny DB, Edwards NM, Dobrilovic N. Surgical outcomes of pulmonary valve infective endocarditis: A US population-based analysis. Int J Cardiol. 2022 Aug 15; 361:50-54.View Related Profiles. PMID: 35597492; DOI: 10.1016/j.ijcard.2022.05.033;
-
Taylor JL, Laks J, Christine PJ, Kehoe J, Evans J, Kim TW, Farrell NM, White CS, Weinstein ZM, Walley AY. Bridge clinic implementation of "72-hour rule" methadone for opioid withdrawal management: Impact on opioid treatment program linkage and retention in care. Drug Alcohol Depend. 2022 Jul 01; 236:109497.View Related Profiles. PMID: 35607834; DOI: 10.1016/j.drugalcdep.2022.109497;
-
Shankar D, Borrelli B, Cobb V, Quintiliani LM, Palfai T, Weinstein Z, Bulekova K, Kathuria H. Text-messaging to promote smoking cessation among individuals with opioid use disorder: quantitative and qualitative evaluation. BMC Public Health. 2022 Apr 06; 22(1):668.View Related Profiles. PMID: 35387648; PMCID: PMC8988312; DOI: 10.1186/s12889-022-13008-z;
Showing 10 of 43 results.
Show More
-
Peterkin A, Davis CS, Weinstein Z. Permanent Methadone Treatment Reform Needed to Combat the Opioid Crisis and Structural Racism. J Addict Med. 2022 Mar-Apr 01; 16(2):127-129.View Related Profiles. PMID: 33758114
-
Kimmel SD, Rosenmoss S, Bearnot B, Weinstein Z, Yan S, Walley AY, Larochelle MR. Northeast Postacute Medical Facilities Disproportionately Reject Referrals For Patients With Opioid Use Disorder. Health Aff (Millwood). 2022 03; 41(3):434-444.View Related Profiles. PMID: 35254930
-
Peterkin A, Laks J, Weinstein ZM. Current Best Practices for Acute and Chronic Management of Patients with Opioid Use Disorder. Med Clin North Am. 2022 Jan; 106(1):61-80.View Related Profiles. PMID: 34823735
-
Barocas JA, Savinkina A, Adams J, Jawa R, Weinstein ZM, Samet JH, Linas BP. Clinical impact, costs, and cost-effectiveness of hospital-based strategies for addressing the US opioid epidemic: a modelling study. Lancet Public Health. 2022 01; 7(1):e56-e64.View Related Profiles. PMID: 34861189; PMCID: PMC8756295; DOI: 10.1016/S2468-2667(21)00248-6;
-
Komaromy M, Tomanovich M, Taylor JL, Ruiz-Mercado G, Kimmel SD, Bagley SM, Saia KM, Costello E, Park TW, LaBelle C, Weinstein Z, Walley AY. Adaptation of a System of Treatment for Substance Use Disorders During the COVID-19 Pandemic. J Addict Med. 2021 Nov-Dec 01; 15(6):448-451.View Related Profiles. PMID: 33298750; PMCID: PMC8562917; DOI: 10.1097/ADM.0000000000000791;
-
-
Montalvo C, von Horn A, Lane CE, Weinstein ZM, Sharma M, Suzuki J. Precipitated Withdrawal, Delirium, and Cerebellar Stroke: The Pharmacology of Buprenorphine Induction in Non-pharmaceutical Fentanyl and the Neuropsychiatric Manifestations of Cerebellar Stroke. Harv Rev Psychiatry. 2021 Sep-Oct 01; 29(5):370-377.View Related Profiles. PMID: 34524778
-
Harris MT, Seliga RK, Fairbairn N, Nolan S, Walley AY, Weinstein ZM, Turnbull J. Outcomes of Ottawa, Canada's Managed Opioid Program (MOP) where supervised injectable hydromorphone was paired with assisted housing. Int J Drug Policy. 2021 12; 98:103400.View Related Profiles. PMID: 34469781; PMCID: PMC8881087; DOI: 10.1016/j.drugpo.2021.103400;
-
Harris MTH, Peterkin A, Bach P, Englander H, Lapidus E, Rolley T, Weimer MB, Weinstein ZM. Correction to: Adapting inpatient addiction medicine consult services during the COVID-19 pandemic. Addict Sci Clin Pract. 2021 Apr 28; 16(1):25.View Related Profiles. PMID: 33910637; PMCID: PMC8079514; DOI: 10.1186/s13722-021-00232-y;
-
-
-
Campbell CI, Saxon AJ, Boudreau DM, Wartko PD, Bobb JF, Lee AK, Matthews AG, McCormack J, Liu DS, Addis M, Altschuler A, Samet JH, LaBelle CT, Arnsten J, Caldeiro RM, Borst DT, Stotts AL, Braciszewski JM, Szapocznik J, Bart G, Schwartz RP, McNeely J, Liebschutz JM, Tsui JI, Merrill JO, Glass JE, Lapham GT, Murphy SM, Weinstein ZM, Yarborough BJH, Bradley KA. PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment. Addict Sci Clin Pract. 2021 01 31; 16(1):9.View Related Profiles. PMID: 33517894; PMCID: PMC7849121; DOI: 10.1186/s13722-021-00218-w;
-
Hagle HN, Martin M, Winograd R, Merlin J, Finnell DS, Bratberg JP, Gordon AJ, Johnson C, Levy S, MacLane-Baeder D, Northup R, Weinstein Z, Lum PJ. Dismantling racism against Black, Indigenous, and people of color across the substance use continuum: A position statement of the association for multidisciplinary education and research in substance use and addiction. Subst Abus. 2021; 42(1):5-12. PMID: 33465013
-
Englander H, Salisbury-Afshar E, Gregg J, Martin M, Snyder H, Weinstein Z, King C. Converging Crises: Caring for Hospitalized Adults With Substance Use Disorder in the Time of COVID-19. J Hosp Med. 2020 10; 15(10):628-630. PMID: 32966196; PMCID: PMC7531943; DOI: 10.12788/jhm.3485;
-
Stein MD, Phillips KT, Herman DS, Keosaian J, Stewart C, Anderson BJ, Weinstein Z, Liebschutz J. Skin-cleaning among hospitalized people who inject drugs: a randomized controlled trial. Addiction. 2021 05; 116(5):1122-1130.View Related Profiles. PMID: 32830383
-
-
Carneiro TS, Awtry E, Dobrilovic N, Fagan MA, Kimmel S, Weinstein ZM, Cervantes-Arslanian AM. Neurological Complications of Endocarditis: A Multidisciplinary Review with Focus on Surgical Decision Making. Semin Neurol. 2019 08; 39(4):495-506.View Related Profiles. PMID: 31533190
-
Kathuria H, Seibert RG, Cobb V, Weinstein ZM, Gowarty M, Helm ED, Wiener RS. Patient and Physician Perspectives on Treating Tobacco Dependence in Hospitalized Smokers With Substance Use Disorders: A Mixed Methods Study. J Addict Med. 2019 Sep/Oct; 13(5):338-345.View Related Profiles. PMID: 31232740
-
D'Amico MJ, Walley AY, Cheng DM, Forman LS, Regan D, Yurkovic A, Samet JH, Weinstein ZM. Which patients receive an addiction consult? A preliminary analysis of the INREACH (INpatient REadmission post-Addiction Consult Help) study. J Subst Abuse Treat. 2019 11; 106:35-42.View Related Profiles. PMID: 31540609; PMCID: PMC6756179; DOI: 10.1016/j.jsat.2019.08.013;
-
-
McNeely J, Troxel AB, Kunins HV, Shelley D, Lee JD, Walley A, Weinstein ZM, Billings J, Davis NJ, Marcello RK, Schackman BR, Barron C, Bergmann L. Study protocol for a pragmatic trial of the Consult for Addiction Treatment and Care in Hospitals (CATCH) model for engaging patients in opioid use disorder treatment. Addict Sci Clin Pract. 2019 02 19; 14(1):5.View Related Profiles. PMID: 30777122; PMCID: PMC6380041; DOI: 10.1186/s13722-019-0135-7;
-
Kathuria H, Seibert RG, Cobb V, Herbst N, Weinstein ZM, Gowarty M, Jhunjhunwala R, Helm ED, Wiener RS. Perceived barriers to quitting cigarettes among hospitalized smokers with substance use disorders: A mixed methods study. Addict Behav. 2019 08; 95:41-48.View Related Profiles. PMID: 30836208; DOI: 10.1016/j.addbeh.2019.02.017;
-
Weinstein ZM, Wakeman SE, Nolan S. Inpatient Addiction Consult Service: Expertise for Hospitalized Patients with Complex Addiction Problems. Med Clin North Am. 2018 Jul; 102(4):587-601. PMID: 29933817; PMCID: PMC6750950; DOI: 10.1016/j.mcna.2018.03.001;
-
-
Mehta AB, Weinstein Z, Walkey AJ. The Untold Toll of the Opioid Crisis on Intensive Care Units in the United States. Ann Am Thorac Soc. 2017 12; 14(12):1763-1765.View Related Profiles. PMID: 29192818
-
Schiff DM, Drainoni ML, Weinstein ZM, Chan L, Bair-Merritt M, Rosenbloom D. A police-led addiction treatment referral program in Gloucester, MA: Implementation and participants' experiences. J Subst Abuse Treat. 2017 Nov; 82:41-47.View Related Profiles. PMID: 29021114
-
Hui D, Weinstein ZM, Cheng DM, Quinn E, Kim H, Labelle C, Samet JH. Very early disengagement and subsequent re-engagement in primary care Office Based Opioid Treatment (OBOT) with buprenorphine. J Subst Abuse Treat. 2017 Aug; 79:12-19.View Related Profiles. PMID: 28673522; PMCID: PMC5522736; DOI: 10.1016/j.jsat.2017.05.010;
-
-
-
-
-
-
This graph shows the total number of publications by year, by first, middle/unknown,
or last author.
| Year | Publications |
|---|
| 2016 | 5 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 6 |
| 2020 | 3 |
| 2021 | 10 |
| 2022 | 10 |
| 2023 | 3 |
2022 Boston University School of Medicine:
Distinguished Faculty of the Month - February
2021 The Association for Multidisciplinary Education and Research in Substance use and Addiction:
Best Workshop Award
2017 Boston University School of Public Health:
Delta Omega Honors Society
2015 American Society of Addiction Medicine :
Ruth Fox Scholarship
2015 The Association for Multidisciplinary Education and Research in Substance use and Addiction:
Conference Travel Award
2014 American Society of Addiction Medicine :
Next Generation Award
2014 Boston Medical Center:
Resident Advocacy Award
2014 Boston Medical Center:
John Noble Scholarship
Zoe Weinstein MD, MS has mentored medical students in the summer research program as well as longitudinally, resulting in national oral presentations and multiple publications including at least one first author publication. She also mentors residents and fellows in research projects which have resulted in national oral presentations and publications. She actively mentors residents and fellows who are interested in careers in primary care and addiction medicine.
Available to Mentor as: (Review Mentor Role Definitions):
-
Career Mentor
-
Education Mentor
-
Project Mentor
-
Research / Scholarly Mentor